Ghost Tree Capital’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.78M Buy
265,000
+95,000
+56% +$1.16M 0.84% 41
2024
Q2
$1.99M Buy
170,000
+50,000
+42% +$778K 0.62% 44
2024
Q1
$2.53M Buy
+120,000
New +$2.14M 0.7% 48
2020
Q4
Sell
-75,000
Closed -$2.06M 54
2020
Q3
$2.06M Buy
+75,000
New +$2.45M 0.6% 35
2016
Q1
Sell
-60,000
Closed -$996K 63
2015
Q4
$996K Hold
60,000
0.41% 42
2015
Q3
$1.32M Buy
+60,000
New +$1.53M 0.6% 54

Other funds holding RGNX

Ghost Tree Capital's RGNX Position: Q3 2024 in Review

Ghost Tree Capital increased its Regenxbio (RGNX) stake by 56% in Q3 2024, buying an estimated $1.16M and bringing the position to 265,000 shares worth $2.78M. The position accounts for 0.84% of the portfolio, ranked #41.

Ghost Tree Capital first reported a position in RGNX in Q3 2015 and has held it in 6 quarters since. 186 funds tracked by Wall St. Rank hold RGNX as of Q3 2024.

  • Ghost Tree Capital held 265,000 shares of Regenxbio worth $2.78M as of Q3 2024.
  • Ghost Tree Capital bought 95,000 Regenxbio shares in Q3 2024, an estimated $1.16M.
  • Regenxbio made up 0.84% of Ghost Tree Capital's portfolio in Q3 2024, its #41 holding.
  • Ghost Tree Capital first reported a position in Regenxbio in Q3 2015 and has held it in 6 quarters since.
  • 186 funds tracked by Wall St. Rank held Regenxbio as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.